effect of B blocker was first evaluated in patient with cardiomyopathy not induced by ischemia and idiopathic which as the most common causes of cardiomyopathy. Effect of BB on Thalassemia cardiomyopathy was evaluated in this study
In this clinical trial, 45 patients with thalassemia cardiomyopathy were randomized to receive either metoprolol (n = 26) or placebo (n = 19). Echocardiography and 6 minute walk test was performed at baseline and repeated after 6 months and the values were compared.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
45
using B blocker in patient group
placebo to control group
Shiraz University of Medical Sciences
Shiraz, Fars, Iran
ejection fraction
LV contractility
Time frame: 6 months
6 minutes walk test
functional capacity
Time frame: 6 months
endsystolic volume
functional capacity
Time frame: 6 months
patient compliance
drug complication,
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.